1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    A couple are happy sitting on their yacht.
    How to invest

    How to build a $250,000 ASX share portfolio starting at zero

    | James Mickleboro

    Are you keen to start building wealth? Here's one strategy you could use.

    Read more »

    Blue Chip Shares

    Top Australian stocks to buy with $5,000 in 2026

    | Aaron Teboneras

    Looking to invest $5,000 in 2026? Here are 3 Australian stocks offering growth, stability, and diversification across key sectors.

    Read more »

    RIO BHP Profit upgrade A business man open his shirt to reveal a superhero style $ on his chest, indicating a strong ASX share price
    How to invest

    How I'd build a high-conviction ASX share portfolio

    | James Mickleboro

    Only the best will do for this portfolio.

    Read more »

    a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Investors were in a good mood today.

    Read more »

    A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
    Blue Chip Shares

    3 ASX 200 blue-chip shares I would buy with $100,000

    | Grace Alvino

    If I had $100,000 to invest today, I’d back proven blue chips built to endure and compound through market cycles.

    Read more »

    Happy healthcare workers in a labs
    Technology Shares

    Prediction: CSL shares could soar past $270 in 2026

    | Samantha Menzies

    Here's what to expect from the Australian-based global biotechnology company this year.

    Read more »

    Beautiful young couple enjoying in shopping, symbolising passive income.
    How to invest

    The simple buy and hold investing lesson that still works with ASX shares today

    | James Mickleboro

    Want to build wealth? Here's the easy way to do it.

    Read more »

    A man in his 30s with a clipped beard sits at his laptop on a desk with one finger to the side of his face and his chin resting on his thumb as he looks concerned while staring at his computer screen.
    Cheap Shares

    Could these ASX 200 losers be among the best shares to buy in 2026?

    | James Mickleboro

    Is the stage set for a big rebound from these shares this year?

    Read more »

    Shot of a mature scientists working on a laptop in a lab.
    Healthcare Shares

    Could CSL shares outperform the ASX 200 in 2026?

    | Grace Alvino

    After shocking investors in 2025, CSL shares may be setting up for a comeback. Here’s why 2026 could look better.

    Read more »

    A man holds his head in his hands after seeing bad news on his laptop screen.
    Healthcare Shares

    Why did CSL shares crash 39% in 2025?

    | James Mickleboro

    Should you be buying the dip? Let's find out.

    Read more »

    A man holding a cup of coffee puts his thumb up and smiles while at laptop.
    Blue Chip Shares

    My best ASX 200 shares to buy in January

    | James Mickleboro

    There is a lot to like about these ASX 200 shares. Here's why they could be best buys.

    Read more »

    A man sits cross-legged in a zen pose on top of his desk as papers fly around his head, keeping calm amid the volatility.
    How to invest

    What I look for in ASX shares when uncertainty is everywhere

    | James Mickleboro

    Expecting a bumpy ride in 2026? Here's how I would handle it.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note